Congress Recommends Public Rulemaking In Puerto Rico: Health & Wellness Industry News Roundup
This article was originally published in The Rose Sheet
Boehringer Ingelheim agrees to divest five types of animal products to close its deal that sends its consumer products business to Sanofi; "healthy" label use comment extended; and more news in brief.
You may also be interested in...
"We spent a lot of time in Massachusetts trying to point out the flaws in the legislation," says CRN government relations chief Mike Greene. CRN and other stakeholders could focus on the Massachusetts bill because no other similar proposals surfaced in other state legislatures this year.
Center for Inquiry reiterates its criticism of homeopathy and calls on FDA to step up vetting of US-marketed homeopathic products.
US trade regulator will require an "inherent contradiction" for homeopathic OTC labels: disclaimers to FDA-compliant label indications indicating a lack of scientific evidence that the product works.